Skip to main content
. Author manuscript; available in PMC: 2022 Jul 5.
Published in final edited form as: Osteoporos Int. 2012 Dec 13;24(7):2049–2059. doi: 10.1007/s00198-012-2233-1

Table 5.

Dietary intake of B vitamins in relation to hip fracture risk among women (n=35,241), the Singapore Chinese Health Study, 1993–2010

Characteristics Basic model Full model
Cases HRa 95 % CI HRb 95 % CI
Thiamin (B1) (mg/1,000 kcal/day)
Q1 (0.23–0.49) 278 1.0 1.0
Q2 (0.49–0.57) 276 1.01 0.85–1.19 1.01 0.85–1.20
Q3 (0.57–0.65) 291 1.05 0.89–1.24 1.04 0.88–1.24
Q4 (0.65–1.34) 335 1.18 1.01–1.39 1.13 0.95–1.33
p for trend 0.03 0.14
Riboflavin (B2) (mg/1,000 kcal/day)
Q1 (0.25–0.50) 298 1.0 1.0
Q2 (0.50–0.59) 304 1.13 0.96–1.33 1.11 0.94–1.32
Q3 (0.59–0.69) 253 1.02 0.86–1.21 0.97 0.80–1.18
Q4 (0.69–3.89) 325 1.04 0.89–1.23 0.92 0.73–1.15
p for trend 0.91 0.29
Niacin (B3) (mg/1,000 kcal/day)
Q1 (3.57–6.19) 360 1.0 1.0
Q2 (6.19–6.94) 297 0.96 0.82–1.11 0.94 0.80–1.09
Q3 (6.94–7.71) 261 0.97 0.83–1.14 0.95 0.81–1.11
Q4 (7.71–10.90) 262 1.05 0.89–1.23 1.00 0.85–1.17
p for trend 0.62 0.93
Pyridoxine (B6) (mg/1,000 kcal/day)
Q1 (0.37–0.61) 417 1.0 1.0
Q2 (0.61–0.69) 285 0.82 0.70–0.95 0.82 0.71–0.96
Q3 (0.69–0.78) 249 0.79 0.68–0.93 0.79 0.67–0.93
Q4 (0.78–1.76) 229 0.77 0.66–0.91 0.78 0.66–0.93
p for trend 0.001 0.002
Folate (B9) (μg/1,000 kcal/day)
Q1 (26.75–78.93) 334 1.0 1.0
Q2 (78.93–96.10) 314 1.04 0.89–1.22 1.05 0.90–1.23
Q3 (96.10–117.21) 265 0.96 0.81–1.13 0.98 0.82–1.16
Q4 (117.21–331.46) 267 1.00 0.85–1.18 1.03 0.86–1.23
Cobalamin (B12) (μg/1,000 kcal/day)
p for trend 0.77 0.97
Q1 (0.01–1.11) 324 1.0 1.0
Q2 (1.11–1.45) 282 1.02 0.87–1.20 1.01 0.86–1.19
Q3 (1.45–1.83) 281 0.99 0.84–1.16 0.96 0.81–1.13
Q4(1.83–6.28) 293 0.97 0.83–1.14 0.90 0.76–1.07
p for trend 0.65 0.20

CI confidence interval

a

HRs were adjusted for age at recruitment (in years), year of recruitment (1993–1995, 1995–1998), dialect group (Hokkien, Cantonese), body mass index (<20, 20–24, 24–28, ≥28 kg/m2), level of education in categories (no formal education, primary school, secondary school or higher), and total energy intake (in kilocalorie)

b

HR, further adjusted for smoking status (never, ex-smokers, current smokers), moderate physical activity (none, 2–3 h weekly, 4+ h weekly), calcium (quartiles, in milligrams/1,000 kcal/day), soy isoflavones (quartiles, in milligrams/1,000 kcal/day), menopausal status (women only; yes, no), use of hormone replacement therapy at recruitment (women only; yes, no), and baseline self-reported physician-diagnosed history of diabetes mellitus and stroke

HHS Vulnerability Disclosure